1. |
MED13L |
ENSGALG00000008238 |
27 |
6 |
- |
- |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
- |
- |
1.000 |
mediator complex subunit 13 like [Source:HGNC Symbol;Acc:HGNC:22962] |
2. |
CALB2 |
ENSGALG00000026903 |
32 |
2.348 |
- |
- |
- |
0.775 |
- |
0.831 |
0.742 |
- |
- |
- |
calbindin 2 [Source:NCBI gene;Acc:396255] |
3. |
BMPR1A |
ENSGALG00000002003 |
20 |
1.756 |
- |
- |
- |
- |
- |
0.756 |
1.000 |
- |
- |
- |
bone morphogenetic protein receptor type 1A [Source:NCBI gene;Acc:396308] |
4. |
MGAT3 |
ENSGALG00000036743 |
5 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase [Source:NCBI gene;Acc:418013] |
5. |
FBXL16 |
ENSGALG00000002443 |
11 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
F-box and leucine rich repeat protein 16 [Source:NCBI gene;Acc:416405] |
6. |
THRB |
ENSGALG00000011294 |
7 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
thyroid hormone receptor beta [Source:NCBI gene;Acc:396431] |
7. |
FAM184B |
ENSGALG00000041854 |
43 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
family with sequence similarity 184 member B [Source:HGNC Symbol;Acc:HGNC:29235] |
8. |
LOC423752 |
ENSGALG00000020899 |
17 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
uncharacterized LOC423752, transcript variant X1 |
9. |
ACSS1L |
ENSGALG00000010225 |
5 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
acyl-CoA synthetase short-chain family member 1-like, transcript variant X3 |
10. |
ENSGALG00000005511 |
ENSGALG00000005511 |
7 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
|
11. |
FAM96A |
ENSGALG00000026448 |
41 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
family with sequence similarity 96 member A [Source:NCBI gene;Acc:415571] |
12. |
CALR3 |
ENSGALG00000003914 |
8 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
calreticulin 3 [Source:HGNC Symbol;Acc:HGNC:20407] |
13. |
IL18RAP |
ENSGALG00000016788 |
1 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
interleukin 18 receptor accessory protein [Source:HGNC Symbol;Acc:HGNC:5989] |
14. |
TRIO |
ENSGALG00000031495 |
233 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
trio Rho guanine nucleotide exchange factor [Source:HGNC Symbol;Acc:HGNC:12303] |
15. |
P4HTM |
ENSGALG00000006937 |
33 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
prolyl 4-hydroxylase, transmembrane [Source:HGNC Symbol;Acc:HGNC:28858] |
16. |
WDR52 |
WDR52 |
37 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
|
17. |
CDK19 |
ENSGALG00000015051 |
26 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
cyclin dependent kinase 19 [Source:HGNC Symbol;Acc:HGNC:19338] |
18. |
SPG20 |
|
22 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
spastic paraplegia 20 (Troyer syndrome), transcript variant X1 |
19. |
TAF5L |
ENSGALG00000011098 |
17 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
TATA-box binding protein associated factor 5 like [Source:HGNC Symbol;Acc:HGNC:17304] |
20. |
GABRA5 |
ENSGALG00000016744 |
12 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
gamma-aminobutyric acid type A receptor alpha5 subunit [Source:HGNC Symbol;Acc:HGNC:4079] |
21. |
GALNT9 |
ENSGALG00000002242 |
219 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
polypeptide N-acetylgalactosaminyltransferase 9 [Source:HGNC Symbol;Acc:HGNC:4131] |
22. |
TAT |
ENSGALG00000000893 |
11 |
1 |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
tyrosine aminotransferase [Source:HGNC Symbol;Acc:HGNC:11573] |
23. |
FIP1L1 |
ENSGALG00000013943 |
15 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
factor interacting with PAPOLA and CPSF1, transcript variant X5 |
24. |
WEE1 |
ENSGALG00000005769 |
294 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
WEE1 G2 checkpoint kinase [Source:NCBI gene;Acc:423045] |
25. |
MIER2 |
ENSGALG00000001108 |
25 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
MIER family member 2 [Source:HGNC Symbol;Acc:HGNC:29210] |
26. |
PAH |
ENSGALG00000012754 |
15 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
phenylalanine hydroxylase [Source:NCBI gene;Acc:408024] |
27. |
PCGF3 |
ENSGALG00000015333 |
7 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
polycomb group ring finger 3 [Source:HGNC Symbol;Acc:HGNC:10066] |
28. |
SLC22A16 |
ENSGALG00000015055 |
21 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
solute carrier family 22 member 16 [Source:HGNC Symbol;Acc:HGNC:20302] |
29. |
DAAM1 |
ENSGALG00000012017 |
81 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
Gallus gallus dishevelled associated activator of morphogenesis 1 (DAAM1), mRNA. [Source:RefSeq mRNA;Acc:NM_001322368] |
30. |
EML5 |
ENSGALG00000010639 |
25 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
echinoderm microtubule associated protein like 5, transcript variant X1 |
31. |
CCDC73 |
ENSGALG00000012103 |
17 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
coiled-coil domain containing 73 [Source:HGNC Symbol;Acc:HGNC:23261] |
32. |
VWA5A |
ENSGALG00000028815 |
19 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
von Willebrand factor A domain containing 5A, transcript variant X5 |
33. |
CRK |
ENSGALG00000002656 |
15 |
1 |
- |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
CRK proto-oncogene, adaptor protein [Source:NCBI gene;Acc:107054794] |
34. |
ENSGALG00000006897 |
ENSGALG00000006897 |
13 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
|
35. |
CD101 |
|
12 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
CD101 molecule, transcript variant X4 |
36. |
MAT2A |
ENSGALG00000015366 |
17 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
methionine adenosyltransferase 2A, transcript variant X1 |
37. |
UGP2 |
ENSGALG00000008855 |
20 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
UDP-glucose pyrophosphorylase 2 [Source:NCBI gene;Acc:373900] |
38. |
CLCA1 |
ENSGALG00000006322 |
5 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
chloride channel accessory 1 [Source:HGNC Symbol;Acc:HGNC:2015] |
39. |
GNB4 |
ENSGALG00000008983 |
26 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
G protein subunit beta 4 [Source:HGNC Symbol;Acc:HGNC:20731] |
40. |
EGLN3 |
ENSGALG00000010001 |
32 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
egl-9 family hypoxia inducible factor 3 [Source:HGNC Symbol;Acc:HGNC:14661] |
41. |
ENO4 |
ENSGALG00000009254 |
19 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
enolase 4 [Source:HGNC Symbol;Acc:HGNC:31670] |
42. |
PCDH7 |
ENSGALG00000033883 |
6 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
protocadherin 7 [Source:HGNC Symbol;Acc:HGNC:8659] |
43. |
ENSGALG00000016601 |
ENSGALG00000016601 |
16 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
|
44. |
XG |
ENSGALG00000029002 |
17 |
0.923 |
- |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
Xg blood group |
45. |
RNF6 |
ENSGALG00000017105 |
11 |
0.909 |
- |
- |
- |
- |
0.909 |
- |
- |
- |
- |
- |
ring finger protein 6 [Source:HGNC Symbol;Acc:HGNC:10069] |
46. |
PGF |
ENSGALG00000026557 |
33 |
0.909 |
- |
- |
- |
- |
- |
- |
0.909 |
- |
- |
- |
placental growth factor [Source:HGNC Symbol;Acc:HGNC:8893] |
47. |
MYT1L |
ENSGALG00000016384 |
147 |
0.895 |
- |
- |
- |
- |
- |
- |
0.895 |
- |
- |
- |
myelin transcription factor 1 like [Source:HGNC Symbol;Acc:HGNC:7623] |
48. |
ATP8A2 |
ENSGALG00000017106 |
31 |
0.889 |
- |
- |
- |
- |
0.889 |
- |
- |
- |
- |
- |
ATPase phospholipid transporting 8A2 [Source:HGNC Symbol;Acc:HGNC:13533] |
49. |
RSPH4A |
RSPH4A |
34 |
0.881 |
- |
- |
- |
0.881 |
- |
- |
- |
- |
- |
- |
|
50. |
CDERMO-1 |
CDERMO-1 |
279 |
0.88 |
- |
- |
- |
- |
- |
- |
0.880 |
- |
- |
- |
|
51. |
ATXN1L |
ENSGALG00000028253 |
17 |
0.879 |
- |
- |
0.879 |
- |
- |
- |
- |
- |
- |
- |
ataxin 1 like [Source:HGNC Symbol;Acc:HGNC:33279] |
52. |
TRPC1 |
ENSGALG00000002639 |
296 |
0.862 |
- |
- |
- |
- |
- |
0.862 |
- |
- |
- |
- |
transient receptor potential cation channel subfamily C member 1 [Source:NCBI gene;Acc:424776] |
53. |
CDCP2 |
ENSGALG00000010752 |
4 |
0.842 |
- |
- |
- |
- |
0.842 |
- |
- |
- |
- |
- |
CUB domain containing protein 2 [Source:HGNC Symbol;Acc:HGNC:27297] |
54. |
C2CD4A |
ENSGALG00000003644 |
98 |
0.838 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.838 |
C2 calcium dependent domain containing 4A |
55. |
MSANTD3 |
ENSGALG00000013403 |
85 |
0.834 |
- |
- |
- |
- |
- |
- |
0.834 |
- |
- |
- |
Myb/SANT DNA binding domain containing 3 [Source:HGNC Symbol;Acc:HGNC:23370] |
56. |
MAGI3 |
ENSGALG00000001816 |
12 |
0.832 |
- |
- |
- |
- |
0.832 |
- |
- |
- |
- |
- |
membrane associated guanylate kinase, WW and PDZ domain containing 3 [Source:NCBI gene;Acc:419877] |
57. |
CCDC33 |
|
7 |
0.83 |
- |
- |
- |
- |
0.830 |
- |
- |
- |
- |
- |
coiled-coil domain containing 33, transcript variant X2 |
58. |
TAF4B |
ENSGALG00000015122 |
28 |
0.83 |
- |
- |
- |
- |
0.830 |
- |
- |
- |
- |
- |
TATA-box binding protein associated factor 4b [Source:HGNC Symbol;Acc:HGNC:11538] |
59. |
NEIL3 |
ENSGALG00000010719 |
47 |
0.829 |
- |
- |
- |
- |
- |
- |
0.829 |
- |
- |
- |
nei like DNA glycosylase 3 [Source:HGNC Symbol;Acc:HGNC:24573] |
60. |
ELOVL3 |
ENSGALG00000025772 |
212 |
0.829 |
- |
- |
- |
- |
- |
- |
0.829 |
- |
- |
- |
Gallus gallus ELOVL fatty acid elongase 3 (ELOVL3), mRNA. [Source:RefSeq mRNA;Acc:NM_001318410] |
61. |
CCDC83 |
ENSGALG00000013247 |
61 |
0.825 |
- |
- |
- |
- |
- |
- |
0.825 |
- |
- |
- |
coiled-coil domain containing 83 [Source:HGNC Symbol;Acc:HGNC:28535] |
62. |
EML4 |
ENSGALG00000009915 |
628 |
0.82 |
- |
- |
- |
- |
- |
- |
0.820 |
- |
- |
- |
echinoderm microtubule associated protein like 4 [Source:HGNC Symbol;Acc:HGNC:1316] |
63. |
CDAN1 |
ENSGALG00000009156 |
110 |
0.813 |
- |
- |
- |
- |
0.813 |
- |
- |
- |
- |
- |
codanin 1, transcript variant X2 |
64. |
HTR2C |
ENSGALG00000005853 |
90 |
0.81 |
- |
- |
- |
- |
- |
0.810 |
- |
- |
- |
- |
Gallus gallus 5-hydroxytryptamine receptor 2C (HTR2C), mRNA. [Source:RefSeq mRNA;Acc:NM_001318421] |
65. |
RYR2 |
ENSGALG00000010812 |
95 |
0.807 |
- |
- |
- |
- |
0.807 |
- |
- |
- |
- |
- |
ryanodine receptor 2 [Source:HGNC Symbol;Acc:HGNC:10484] |
66. |
ADAMTS2 |
ENSGALG00000032974 |
141 |
0.801 |
- |
- |
- |
- |
- |
0.801 |
- |
- |
- |
- |
ADAM metallopeptidase with thrombospondin type 1 motif 2 [Source:HGNC Symbol;Acc:HGNC:218] |
67. |
SYCP1 |
ENSGALG00000002511 |
13 |
0.798 |
- |
- |
- |
- |
0.798 |
- |
- |
- |
- |
- |
synaptonemal complex protein 1 [Source:HGNC Symbol;Acc:HGNC:11487] |
68. |
TOX3 |
ENSGALG00000034649 |
54 |
0.796 |
- |
- |
- |
- |
- |
- |
0.796 |
- |
- |
- |
TOX high mobility group box family member 3 [Source:NCBI gene;Acc:415724] |
69. |
CRYBB1 |
ENSGALG00000005630 |
11 |
0.796 |
- |
- |
- |
- |
- |
- |
0.796 |
- |
- |
- |
crystallin beta B1 [Source:NCBI gene;Acc:374000] |
70. |
NR3C1 |
ENSGALG00000032992 |
4 |
0.795 |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
- |
nuclear receptor subfamily 3 group C member 1 [Source:NCBI gene;Acc:416343] |
71. |
U2_1 |
U2_1 |
13 |
0.795 |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
- |
|
72. |
SMTN |
|
18 |
0.795 |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
- |
smoothelin, transcript variant X2 |
73. |
WDR78 |
ENSGALG00000045792 |
6 |
0.795 |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
- |
WD repeat domain 78 [Source:HGNC Symbol;Acc:HGNC:26252] |
74. |
DNAJC28 |
ENSGALG00000037414 |
6 |
0.795 |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
- |
DnaJ heat shock protein family (Hsp40) member C28 [Source:HGNC Symbol;Acc:HGNC:1297] |
75. |
OLFML1 |
ENSGALG00000027184 |
19 |
0.795 |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
- |
olfactomedin like 1 [Source:HGNC Symbol;Acc:HGNC:24473] |
76. |
MOGAT2 |
ENSGALG00000014170 |
10 |
0.795 |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
- |
monoacylglycerol O-acyltransferase 2 [Source:HGNC Symbol;Acc:HGNC:23248] |
77. |
RBM15 |
ENSGALG00000000401 |
22 |
0.795 |
- |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
RNA binding motif protein 15 [Source:HGNC Symbol;Acc:HGNC:14959] |
78. |
MRAP2 |
ENSGALG00000015838 |
7 |
0.795 |
- |
- |
- |
0.795 |
- |
- |
- |
- |
- |
- |
Gallus gallus melanocortin 2 receptor accessory protein 2 (MRAP2), mRNA. [Source:RefSeq mRNA;Acc:NM_001320907] |
79. |
TMEM230 |
ENSGALG00000036876 |
55 |
0.794 |
- |
- |
- |
- |
- |
- |
0.794 |
- |
- |
- |
transmembrane protein 230 [Source:NCBI gene;Acc:419518] |
80. |
MAGI2 |
|
1111 |
0.794 |
- |
- |
- |
- |
- |
0.794 |
- |
- |
- |
- |
membrane associated guanylate kinase, WW and PDZ domain containing 2, transcript variant X12 |
81. |
ENSGALG00000026696 |
ENSGALG00000026696 |
126 |
0.794 |
- |
- |
- |
- |
- |
0.794 |
- |
- |
- |
- |
|
82. |
CRTAM |
ENSGALG00000006527 |
6 |
0.777 |
- |
- |
- |
0.777 |
- |
- |
- |
- |
- |
- |
cytotoxic and regulatory T cell molecule [Source:NCBI gene;Acc:395342] |
83. |
ENSGALG00000018879 |
ENSGALG00000018879 |
9 |
0.772 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.772 |
|
84. |
LOC422926 |
ENSGALG00000027090 |
16 |
0.767 |
- |
- |
- |
- |
0.767 |
- |
- |
- |
- |
- |
uncharacterized LOC422926 |
85. |
ZNFX1 |
ENSGALG00000004859 |
33 |
0.764 |
- |
- |
- |
- |
- |
- |
0.764 |
- |
- |
- |
zinc finger NFX1-type containing 1 [Source:HGNC Symbol;Acc:HGNC:29271] |
86. |
TMEM240 |
ENSGALG00000035387 |
14 |
0.762 |
- |
- |
- |
0.762 |
- |
- |
- |
- |
- |
- |
transmembrane protein 240 [Source:HGNC Symbol;Acc:HGNC:25186] |
87. |
CXorf57 |
ENSGALG00000008990 |
31 |
0.761 |
- |
- |
- |
- |
- |
0.761 |
- |
- |
- |
- |
chromosome X open reading frame 57 [Source:HGNC Symbol;Acc:HGNC:25486] |
88. |
GNAL |
ENSGALG00000013785 |
108 |
0.759 |
- |
- |
0.759 |
- |
- |
- |
- |
- |
- |
- |
G protein subunit alpha L [Source:NCBI gene;Acc:474379] |
89. |
TMEM52B |
ENSGALG00000034698 |
169 |
0.756 |
- |
- |
- |
- |
- |
0.756 |
- |
- |
- |
- |
transmembrane protein 52B [Source:HGNC Symbol;Acc:HGNC:26438] |
90. |
SAMSN1 |
ENSGALG00000040926 |
88 |
0.755 |
- |
- |
- |
- |
0.755 |
- |
- |
- |
- |
- |
SAM domain, SH3 domain and nuclear localization signals 1 [Source:NCBI gene;Acc:418470] |
91. |
IMPDH2 |
ENSGALG00000006910 |
77 |
0.753 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.753 |
inosine monophosphate dehydrogenase 2 [Source:NCBI gene;Acc:416058] |
92. |
BRAT1 |
ENSGALG00000004348 |
158 |
0.753 |
- |
- |
- |
- |
- |
- |
0.753 |
- |
- |
- |
BRCA1 associated ATM activator 1, transcript variant X3 |
93. |
CLEC18B |
ENSGALG00000027183 |
284 |
0.752 |
- |
- |
- |
- |
0.752 |
- |
- |
- |
- |
- |
C-type lectin domain family 18 member B, transcript variant X2 |
94. |
NR1D1 |
ENSGALG00000001035 |
3 |
0.751 |
- |
- |
- |
- |
0.751 |
- |
- |
- |
- |
- |
nuclear receptor subfamily 1, group D, member 1, transcript variant X2 |
95. |
SLC24A5 |
ENSGALG00000004885 |
8 |
0.751 |
- |
- |
- |
- |
0.751 |
- |
- |
- |
- |
- |
solute carrier family 24 member 5 [Source:NCBI gene;Acc:415431] |
96. |
SLC15A5 |
ENSGALG00000013097 |
213 |
0.75 |
- |
- |
- |
0.750 |
- |
- |
- |
- |
- |
- |
solute carrier family 15 member 5 [Source:HGNC Symbol;Acc:HGNC:33455] |
97. |
ENSGALG00000021702 |
ENSGALG00000021702 |
2 |
0.747 |
- |
- |
- |
0.747 |
- |
- |
- |
- |
- |
- |
|
98. |
INPP4A |
ENSGALG00000029709 |
48 |
0.747 |
- |
- |
0.747 |
- |
- |
- |
- |
- |
- |
- |
inositol polyphosphate-4-phosphatase type I A [Source:HGNC Symbol;Acc:HGNC:6074] |
99. |
OBSCN |
ENSGALG00000032534 |
20 |
0.746 |
- |
- |
- |
- |
0.746 |
- |
- |
- |
- |
- |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF [Source:HGNC Symbol;Acc:HGNC:15719] |
100. |
ADGB |
ENSGALG00000012317 |
28 |
0.743 |
- |
- |
- |
- |
- |
0.743 |
- |
- |
- |
- |
androglobin [Source:HGNC Symbol;Acc:HGNC:21212] |